Hubei Teyer Pharmaceutical Co., Ltd is a leading manufacturer of Ganciclovir, CBZ-valganciclovir, Valganciclovir hydrochloride and Surfactant lauryl sulfoacetate (SLSA). All our products are produced according to BP/USP/EP/CP/IP/JP standard .
| Product Name | CAS No. | PURITY | USAGE |
|---|---|---|---|
| API | |||
| Ganciclovir | 82410-32-0 | 99%min | Anti virus |
| Valacyclovir Hydrochloride | 124832-27-5 | 99%min | Anti virus |
| Valganciclovir Hydrochloride | 175865-59-5 | 99%min | Anti virus |
| Tiopronin | 1953-02-2 | 99%min | Anti hepatitis |
| Alpha-Asarone | 2883-98-9 | 99%min | Antibacterial anti-inflammatory |
| Zolmitriptan | 139264-17-8 | 99%min | Antimigraine agents |
| Mycophenolate mofetil | 115007-34-6 | 99%min | Immunosuppressants |
| Levamisole hydrochloride | 16595-80-5 | 99%min | Broad-spectrum Deworming |
| Racecadotril | 81110-73-8 | 99%min | Acute diarrhea treatment |
| Esmolol hydrochloride | 81161-17-3 | 99%min | Arrhythmia Treatment |
| Vandetanib | 443913-73-3 | 99%min | Antitumous agent |
| Ponatinib | 943319-70-8 | 99%min | Antitumous agent |
| Captopril | 62571-86-2 | 99%min | Antihypertensive drugs |
| Ecabet sodium | 86408-72-2 | 99%min | Gastritis Treatment |
| Sodium new houttuyfonate | 58761-87-8 | 99%min | Antibacterial anti-inflammatory |
| INTERMEDIATES | |||
| Triacetyl methoxyglycerin | 86357-13-3 | 98%min | GCV |
| 1,3-Dichloro-2-(acetoxymethoxy)propane | 89281-73-2 | 90%min | GCV |
| Chlorine condensate compound (LSW) | -- | 85%min | GCV |
| Ganciclovir Mono-O-acetate | 88110-89-8 | 99%min | VGCV |
| CBZ-valine-Ganciclovir | 194154-40-0 | 99%min | VGCV |
| O-Acetyl N- Carbobenzyloxy Valganciclovir | 194159-22-3 | 99%min | VGCV |
| Triacetyl-ganciclovir | 86357-14-4 | 98%min | GCV |
| Mono Benzyl Ganciclovir | 119089-68-8 | 98%min | VGCV |
| Benzyl Dipropionate(BDP) | 194204-51-8 | VGCV | |
| 2-[[(E)-(3-chloro-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]-3-methylbutanoic acid | 43203-52-7 | VGCV | |
| N-[(5-Chloro-2-hydroxyphenyl)phenylmethylene]-L-valine | 38075-43-3 | VGCV | |
| Vandetanib intermediates: | Antitumous agent | ||
| 7-(benzyloxy)-N-(4-bromo-2-fluorophenyl)-6-methoxyquinazolin-4-amine | 768350-54-5 | ||
| 4-(4-Bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline | 196603-96-0 | ||
| 1-methyl-piperidine-4-carboxylic acid | 68947-43-3 | ||
| Pranatinib intermediate: | |||
| 3-trifluoromethyl-4-[(4-methylpiperazin-1-yl)methyl]aniline | 694499-26-8 | AJC-02 | |
| PERSONAL CARE | |||
| Sodium Lauryl Sulfoacetate (SLSA) | 1847-58-1 | 75%min | Anionic surface active agent |
| Sodium Lauroyl Methyl Isethionate （SLMI） | 928663-45-0 | 75%min | Anionic surface active agent |
.